Additionally, the Calcium-sensing receptor (CaSR) and its agonists (e.g., calcimimetics) enhance extracellular calcium sensitivity, mitigating hypercalcemia-related complications like osteoporosis and extending therapeutic potential to fracture healing and bone tumors 6. This evidence concerns the gene CASR and osteoporosis.